1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    



















































































































    Clinical Features of Cytotoxic Lesions of the Corpus Callosum Associated with Aneurysmal Subarachnoid Hemorrhage | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      



          


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleAdult Brain

  
      

  
      
Clinical Features of Cytotoxic Lesions of the Corpus Callosum Associated with Aneurysmal Subarachnoid Hemorrhage
  
    	
H. Toi, K. Yagi, S. Matsubara, K. Hara and M. Uno

  
    	
American Journal of Neuroradiology June 2021,  42 (6) 1046-1051; DOI: https://doi.org/10.3174/ajnr.A7055 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵
    1. 

    2. Bulakbasi  N, 
    3. Kocaoglu  M, 
    4. Tayfun  C, et al
    . Transient splenial lesion of the corpus callosum in clinically mild influenza-associated encephalitis/encephalopathy. AJNR Am J Neuroradiol 2006;27:1983–86 pmid:17032879
    PubMed
  2. 2.↵
    1. 

    2. Gallucci  M, 
    3. Limbucci  N, 
    4. Paonessa  A, et al
    . Reversible focal splenial lesions. Neuroradiology 2007;49:541–44 doi:10.1007/s00234-007-0235-z pmid:17522852
    CrossRefPubMedWeb of Science
  3. 3.↵
    1. 

    2. Garcia-Monco  JC, 
    3. Cortina  IE, 
    4. Ferreira  E, et al
    . Cytotoxic lesions of the corpus callosum syndrome (RESLES): what's in a name? J Neuroimaging 2011;21:e1–14 doi:10.1111/j.1552-6569.2008.00279.x pmid:18681931
    CrossRefPubMedWeb of Science
  4. 4.↵
    1. 

    2. Gürtler  S, 
    3. Ebner  A, 
    4. Tuxhorn  I, et al
    . Transient lesion in the splenium of the corpus callosum and antiepileptic drug withdrawal. Neurology 2005;65:1032–36 doi:10.1212/01.wnl.0000179301.96652.27 pmid:16217055
    Abstract/FREE Full Text
  5. 5.↵
    1. 

    2. Güven  H, 
    3. Delibaş  S, 
    4. Comoğlu  SS
    . Transient lesion in the splenium of the corpus callosum due to carbamazepine. Turk Neurosurg 2008;18:264–70 pmid:18814116
    PubMed
  6. 6.↵
    1. 

    2. Kim  SS, 
    3. Chang  KH, 
    4. Kim  ST, et al
    . Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? AJNR Am J Neuroradiol 1999;20:125–29 pmid:9974067
    Abstract/FREE Full Text
  7. 7.↵
    1. 

    2. Maeda  M, 
    3. Tsukahara  H, 
    4. Terada  H, et al
    . Cytotoxic lesions of the corpus callosum with restricted diffusion in a wide spectrum of diseases and conditions. J Neuroradiol 2006;33:229–36 doi:10.1016/S0150-9861(06)77268-6 pmid:17041527
    CrossRefPubMedWeb of Science
  8. 8.↵
    1. 

    2. Mori  H, 
    3. Maeda  M, 
    4. Takanashi  J, et al
    . Cytotoxic lesions of the corpus callosum in the corpus callosum following rapid withdrawal of carbamazepine after neurosurgical decompression for trigeminal neuralgia. J Clin Neurosci 2012;19:1182–84 doi:10.1016/j.jocn.2011.09.017 pmid:22349431
    CrossRefPubMed
  9. 9.↵
    1. 

    2. Takanashi  J, 
    3. Barkovich  AJ, 
    4. Shiihara  T, et al
    . Widening spectrum of a reversible splenial lesion with transiently reduced diffusion. AJNR Am J Neuroradiol 2006;27:836–38 pmid:16611774
    PubMedWeb of Science
  10. 10.↵
    1. 

    2. Takanashi  J, 
    3. Tada  H, 
    4. Maeda  M, et al
    . Encephalopathy with a reversible splenial lesion is associated with hyponatremia. Brain Dev 2009;31:217–20 doi:10.1016/j.braindev.2008.04.002 pmid:18490123
    CrossRefPubMedWeb of Science
  11. 11.↵
    1. 

    2. Abe  E, 
    3. Kajiwara  H, 
    4. Goda  M, et al
    . Clinically mild encephalitis/encephalopathy with a reversible splenial lesion, indistinguishable from multiple cerebral infarction: a case report [in Japanese]. Nosotchu 2014;36:443–48 doi:10.3995/jstroke.36.443
    CrossRef
  12. 12.↵
    1. 

    2. Tung  CS, 
    3. Wu  SL, 
    4. Tsou  JC, et al
    . Marchiafava-Bignami disease with widespread lesions and complete recovery. AJNR Am J Neuroradiol 2010;31:1506–07 doi:10.3174/ajnr.A1897 pmid:20019108
    Abstract/FREE Full Text
  13. 13.↵
    1. 

    2. Tada  H, 
    3. Takanashi  J, 
    4. Barkovich  AJ, et al
    . Clinically mild encephalitis/encephalopathy with a cytotoxic lesions of the corpus callosum. Neurology 2004;63:1854–58 doi:10.1212/01.wnl.0000144274.12174.cb pmid:15557501
    Abstract/FREE Full Text
  14. 14.↵
    1. 

    2. Starkey  J, 
    3. Kobayashi  N, 
    4. Numaguchi  Y, et al
    . Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations. Radiographics 2017;37:562–76 doi:10.1148/rg.2017160085 pmid:28165876
    CrossRefPubMed
  15. 15.↵
    1. 

    2. Gaur  P, 
    3. Dixon  L, 
    4. Jones  B, et al
    . COVID-19-associated cytotoxic lesions of the corpus callosum. AJNR Am J Neuroradiol 2020;41:1905–07 doi:10.3174/ajnr.A6713 pmid:32819904
    Abstract/FREE Full Text
  16. 16.↵
    1. 

    2. Yamazaki  T, 
    3. Sasaki  T, 
    4. Kubota  T, et al
    . Reversible focal splenial lesion of the corpus callosum in aneurysmal subarachnoid hemorrhage [in Japanese]. Progress in CI 2012;34:93–98
  17. 17.↵
    1. 

    2. Rinkel  GJ, 
    3. van Gijn  J, 
    4. Wijdicks  EF
    . Subarachnoid hemorrhage without detectable aneurysm: a review of the causes. Stroke 1993;24:1403–09 doi:10.1161/01.str.24.9.1403 pmid:8362440
    Abstract/FREE Full Text
  18. 18.↵
    1. 

    2. Vergouwen  MD, 
    3. Vermeulen  M, 
    4. van Gijn  J, et al
    . Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 2010;41:2391–95 doi:10.1161/STROKEAHA.110.589275 pmid:20798370
    Abstract/FREE Full Text
  19. 19.↵
    1. 

    2. Aboitiz  F, 
    3. Scheibel  AB, 
    4. Fisher  RS, et al
    . Fiber composition of the human corpus callosum. Brain Res 1992;598:143–53 doi:10.1016/0006-8993(92)90178-c pmid:1486477
    CrossRefPubMedWeb of Science
  20. 20.↵
    1. 

    2. Uchida  K, 
    3. Shirakawa  M, 
    4. Sakamoto  D, et al
    . A case of reversible splenial lesion after surgical resection of arteriovenous malformation [in Japanese]. Brain Nerve 2013;65:212–13 pmid:23399678
    PubMed
  21. 21.↵
    1. 

    2. Sorimachi  T, 
    3. Yajima  N, 
    4. Sasaki  O, et al
    . Hematoma in the splenium of the corpus callosum in the subacute stage of subarachnoid hemorrhage: three case reports. Neurol Med Chir (Tokyo) 2010;50:209–12 doi:10.2176/nmc.50.209 pmid:20339269
    CrossRefPubMed
  22. 22.↵
    1. 

    2. Hadeishi  H, 
    3. Suzuki  A, 
    4. Yasui  N, et al
    . Diffusion-weighted magnetic resonance imaging in patients with subarachnoid hemorrhage. Neurosurgery 2002;50:741–47 doi:10.1097/00006123-200204000-00010 pmid:11904024
    CrossRefPubMedWeb of Science
  23. 23.↵
    1. 

    2. Graetz  D, 
    3. Nagel  A, 
    4. Schlenk  F, et al
    . High ICP as trigger of proinflammatory IL-6 cytokine activation in aneurysmal subarachnoid hemorrhage. Neurol Res 2010;32:728–35 doi:10.1179/016164109X12464612122650 pmid:19682408
    CrossRefPubMed
  24. 24.↵
    1. 

    2. Fujita  K, 
    3. Kusunoki  T, 
    4. Noda  M, et al
    . Normal pressure hydrocephalus (NPH) following subarachnoid hemorrhage (SAH)-clinical consideration of CT and development of hydrocephalus after SAH [in Japanese]. No To Shinkei 1981;33:845–51 pmid:7284211
    PubMed
  25. 25.↵
    1. 

    2. Liu  WM, 
    3. Lin  CH
    . A reversible stroke-like splenial lesion in viral encephalopathy. Acta Neurol Taiwan 2013;22:117–21 pmid:24030090
    PubMed
  26. 26.↵
    1. 

    2. Moritani  T, 
    3. Ekholm  S, 
    4. Westesson  PL
    . Diffusion-Weighted MR Imaging of the Brain. 2nd ed. Springer-Verlag; 2009:37–38
  27. 27.↵
    1. 

    2. Gaetani  P, 
    3. Tartara  F, 
    4. Pignatti  P, et al
    . Cisternal CSF levels of cytokines after subarachnoid hemorrhage. Neurol Res 1998;20:337–42 doi:10.1080/01616412.1998.11740528 pmid:9618698
    CrossRefPubMedWeb of Science
  28. 28.↵
    1. 

    2. Mathiesen  T, 
    3. Edner  G, 
    4. Ulfarsson  E, et al
    . Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage. J Neurosurg 1997;87:215–20 doi:10.3171/jns.1997.87.2.0215 pmid:9254084
    CrossRefPubMedWeb of Science
  29. 29.↵
    1. 

    2. Kahilogullari  G, 
    3. Comert  A, 
    4. Ozdemir  M, et al
    . Arterial vascularization patterns of the splenium: an anatomical study. Clin Anat 2013;26:675–81 doi:10.1002/ca.22114 pmid:23564403
    CrossRefPubMed
  30. 30.↵
    1. 

    2. Kakou  M, 
    3. Velut  S, 
    4. Destrieux  C
    . Arterial and venous vascularization of the corpus callosum [in French]. Neurochirurgie 1998;44(1 Suppl):31–37
    PubMed
  31. 31.↵
    1. 

    2. Tetsuka  S
    . Reversible lesion in the splenium of the corpus callosum. Brain Behav 2019;9:e0144 doi:10.1002/brb3.1440 pmid:31588684
    CrossRefPubMed
  32. 32.↵
    1. 

    2. Satoh  S, 
    3. Suzuki  Y, 
    4. Ikegaki  I, et al
    . The effects of HA1077 on the cerebral circulation after subarachnoid haemorrhage in dogs. Acta Neurochir (Wien) 1991;110:185–88 doi:10.1007/BF01400689 pmid:1927613
    CrossRefPubMed
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Clinical Features of Cytotoxic Lesions of the Corpus Callosum Associated with Aneurysmal Subarachnoid Hemorrhage
  
    	
H. Toi, K. Yagi, S. Matsubara, K. Hara, M. Uno

  
    	
American Journal of Neuroradiology Jun 2021, 42 (6) 1046-1051; DOI: 10.3174/ajnr.A7055 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement